Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson's Disease: A Meta-Analysis of Randomised Controlled Trials

Author： Etminan M.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.11, 2001-01, pp. : 863-868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson's Disease: Meta-Analysis of Randomized Controlled Trials

By Kulisevsky Jaime   Pagonabarraga Javier  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 147-161

Adis International

Access to resources Recommend Favorite

Use of Cardioselective β-Blockers in Patients with Chronic Obstructive Pulmonary Disease: a Meta-Analysis of Randomized, Placebo-controlled, Blinded Trials

By Ni Y   Shi G   Wan H  

The Journal of International Medical Research, Vol. 40, Iss. 6, 2012-11 ,pp. : 2051-2065

Field House Publishing

Access to resources Recommend Favorite

Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson’s Disease: A Meta-Analysis

By Etminan M.  

Drug Safety, Vol. 26, Iss. 6, 2003-01 ,pp. : 439-444

Adis International

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron   Jankovic Joseph  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite

Ginseng for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 529-536

Bentham Science Publishers

Access to resources Recommend Favorite